ACADIA Pharmaceuticals Inc. (ACAD)
NASDAQ: ACAD · IEX Real-Time Price · USD
17.77
+0.12 (0.68%)
Jul 12, 2024, 4:00 PM EDT - Market closed

ACADIA Pharmaceuticals Stock Forecast

Stock Price Forecast

The 20 analysts with 12-month price forecasts for ACAD stock have an average target of 29.3, with a low estimate of 19 and a high estimate of 42. The average target predicts an increase of 64.88% from the current stock price of 17.77.

Analyst Consensus: Buy
Target Low Average Median High
Price $19 $29.3 $29 $42
Change +6.92% +64.88% +63.20% +136.35%

Analyst Ratings

The average analyst rating for ACAD stock from 20 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

Rating Feb '24Mar '24Apr '24May '24Jun '24Jul '24
Strong Buy 766666
Buy 777788
Hold 666666
Sell 000000
Strong Sell 000000
Total 201919192020

Latest Forecasts

Analyst Firm Rating Rating Action Price Target Upside Date
Morgan Stanley
Morgan Stanley
Buy
Maintains
$30$28
Buy Maintains $30$28 +57.57% Jul 12, 2024
BMO Capital
BMO Capital
Buy
Initiates
$31
Buy Initiates $31 +74.45% Jun 27, 2024
RBC Capital
RBC Capital
Buy
Reiterates
$29
Buy Reiterates $29 +63.20% Jun 25, 2024
B of A Securities
B of A Securities
Hold
Maintains
$26$22
Hold Maintains $26$22 +23.80% May 10, 2024
Needham
Needham
Strong Buy
Reiterates
$30
Strong Buy Reiterates $30 +68.82% May 9, 2024
More Analyst Ratings

Financial Forecast

Revenue This Year
972.94M
from 726.44M
Increased by 33.93%
Revenue Next Year
1.10B
from 972.94M
Increased by 12.65%
EPS This Year
0.60
from -0.37
EPS Next Year
1.15
from 0.60
Increased by 93.61%
Year 2019202020212022202320242025202620272028
Revenue
339.08M441.76M484.15M517.24M726.44M972.94M1.10B1.24B1.38B1.52B
Revenue Growth
51.50%30.28%9.60%6.83%40.45%33.93%12.65%12.96%11.71%10.20%
EPS
-1.60-1.79-1.05-1.34-0.370.601.151.682.262.73
EPS Growth
------93.61%45.52%34.58%20.71%
Forward PE
-----29.8415.4210.597.876.52
No. Analysts -----21211888
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue 20242025202620272028
High 1.0B 1.3B 1.4B 1.6B 2.0B
Avg 972.9M 1.1B 1.2B 1.4B 1.5B
Low 901.1M 983.1M 1.1B 1.2B 1.2B

Revenue Growth

Revenue Growth 20242025202620272028
High
41.8%
29.9%
26.6%
31.5%
42.4%
Avg
33.9%
12.6%
13.0%
11.7%
10.2%
Low
24.0%
1.0%
-2.6%
-5.3%
-11.8%

EPS Forecast

EPS 20242025202620272028
High 0.89 2.23 3.14 4.10 4.59
Avg 0.60 1.15 1.68 2.26 2.73
Low 0.28 0.51 0.47 0.60 0.80

EPS Growth

EPS Growth 20242025202620272028
High -
275.3%
172.3%
144.1%
103.2%
Avg -
93.6%
45.5%
34.6%
20.7%
Low -
-14.4%
-59.2%
-64.4%
-64.4%
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.